GlassScriptPhysician profile
Dean S Spellman
NPI 1578574935
$6,021.92
in general payments reported to CMS, 2019-2025
25 companies · $1,160 in 2025
The $1,160 reported for 2025 was more than what 83% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $166 · 2021: $736 · 2022: $486 · 2023: $1,413 · 2024: $1,661 · 2025: $1,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,234.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $880.67 | 2019-2025 | Apligraf, Puraply Wound Matrix, Nushield |
| Paratek Pharmaceuticals, INC. | $619.87 | 2021-2025 | Nuzyra |
| Next Science LLC | $594.78 | 2023-2024 | Blastx, Surgx, Xperience |
| Abbvie INC. | $582.84 | 2021-2024 | Dalvance |
| Smith+Nephew, INC. | $414.21 | 2019-2025 | Grafix Pl, Acticoat 4" X 4", Iodosorb Ointment 40g USA |
| Treace Medical Concepts, INC. | $396.39 | 2022-2024 | |
| Bioventus LLC | $284.10 | 2022-2023 | Theragenesis Bilayer Wound Matrix |
| Horizon Therapeutics Plc | $255.12 | 2021-2023 | Krystexxa |
| Stryker Corporation | $226.47 | 2024-2025 | Dart-Fire, Easyfuse |
| Abbott Laboratories | $216.67 | 2022-2023 | Diamondback Peripheral |
| Polynovo North America LLC | $171.31 | 2024 | Novosorb Btm |
| Globus Medical, INC. | $170.31 | 2025 | Senza |
| Paragon 28, INC. | $141.50 | 2021 | |
| Spr Therapeutics, INC | $141.39 | 2025 | Sprint Pns System |
| Advanced Oxygen Therapy INC. | $140.00 | 2024 | Topical Oxygen Chamber For Extremities |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $129.91 | 2019 | |
| Ibsa Pharma INC. | $125.00 | 2023 | Licart |
| Ani Pharmaceuticals, INC. | $125.00 | 2024 | Purified Cortrophin Gel |
| Vertex Pharmaceuticals Incorporated | $121.91 | 2025 | |
| Amgen INC. | $91.14 | 2024 | Krystexxa |
| Aroa Biosurgery Incorporated | $82.69 | 2024 | |
| Medtronic, INC. | $51.78 | 2023 | Intellis Adaptivestim |
| Alfasigma USA, INC. | $22.79 | 2022 | |
| Celgene Corporation | $18.71 | 2019 | |
| Kerecis Limited | $17.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Spellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.